Skip to main content
. 2023 Jul 2;59(7):1236. doi: 10.3390/medicina59071236

Table 2.

Results of the univariable analysis. Outcome: Failure of conservative antibiotic therapy +/− percutaneous drainage.

Variable Success Group
n = 46 (65.7%)
Failure Group
n = 25 (34.3%)
p Value Odds Ratio Mean Difference 95% CI
Age (years) ± mean difference (MD) 63.9 ± 14.7 57.0 ± 13.1 0.056 6.96 −0.18; 0.99
Sex (Male) n. (%) 21 (45.6%) 14 (56.0%) 0.405 0.660 0.25; 1.76
BMI (Kg/m2) ± mean difference (MD) 26.5 ± 4.6 25.8 ± 3.5 0.615 0.74 −0.50; 0.85
Charlson’s Comorbidity Index ± mean difference (MD) 2.0 ± 0.2 2.0 ± 0.3 0.524 0.28 −0.34; 0.65
Diabetes 4 (8.7%) 1 (4.0%) 0.460 0.438 0.05; 4.14
Chronic renal failure 3 (6.5%) 1 (4.0%) 0.660 0.597 0.06; 6.06
Corticosteroid therapy 2 (4.3%) 1 (4.0%) 0.945 0.917 0.08; 10.60
Heart failure - 1 (4.0%) 0.172 5.690 0.22; 142
Obesity 4 (8.7%) 3 (12.0%) 0.797 0.804 0.15; 4.25
Coagulopathy - 1 (4.0%) 0.172 5.690 0.22; 145
Hypertension 22 (47.8%) 8 (32.0%) 0.197 0.513 0.19; 1.42
Chronic Obstructive Pulmonary Disease (COPD) 1 (2.2) 2 (8.0%) 0.244 3.910 0.34; 45.50
Renal failure (N. %) 12 (26.1%) 5 (20.0%) 0.566 0.708 0.21; 2.31
Coronaropathy 6 (13.0%) 2 (8.0%) 0.521 0.580 0.11; 3.11
Tobacco Smoking 3 (6.5%) 8 (32.0%) 0.007 7.330 1.55; 34.70
Alcohol drinking 2 (4.3%) 5 (20.0%) 0.071 4.770 0.79; 28.70
Leukocytes × 103/μL ± mean difference (MD) 14.1 ± 4.9 13.7 ± 3.6 0.716 0.42 −0.40; 0.59
CRP mg/L ± mean difference (MD) 101.4 ± 17.8 144.1 ± 21.7 0.345 −15.30 −0.91; 0.52
Anemia (Hb < 12 g/dL) 13.0 ± 1.4 13.2 ± 1.7 0.665 −0.18 −0.60; 0.38
Platelets × 103/μL ± mean difference (MD) 258 ± 13.8 299 ± 18.2 0.087 −32.11 −0.93; 0.06
Procalcitonin ng/mL ± mean difference (MD) 0.1 ± 6.6 0.3 ± 0.1 0.601 7.14 −1.20; 1.76
Fever (>38 °C) 19 (41.3%) 6 (24.0%) 0.662 1.301 0.40; 4.19
Systolic blood pressure (mmHg) ± mean difference (MD) 130 ± 16.5 135 ± 19.1 0.254 −1.52 −0.81; 0.22
Tachycardia (>100 bpm) 12 (26.1%) 10 (40.0%) 0.226 1.892 0.67; 5.32
Number of previous episodes of acute diverticulitis (previous episodes) 36 (78.2%)
(0 episodes)
4 (8.7%)
(1 episode)
6 (13.0%)
(>1 episodes)
22 (88.0%)
(0 episodes)
3 (12.0%)
(1 episode)
-
(>1 episodes)
0.163 0.14; 2.41
Diameter of the abscess on CT (mm) ± mean difference (MD) 40.0 ± 4.3 50.0 ± 10.1 0.195 −14.43 −1.01; 0.13
Number of abscesses on CT 38 (82.6%)
(1 abscess)
5 (10.9%)
(2 abscesses)
3 (6.5%)
(>2 abscesses)
23 (92.0%)
(1 abscess)
2 (8.0%)
(2 abscesses)
-
(>2 abscesses)
0.521
0.600 0.11; 3.16
Hinchey stage IIa 21 (45.6%) 6 (24.0%) 0.081 0.376 0.12; 1.11
Hinchey stage IIb 25 (54.4%) 19 (76.0%)
Presence of air bubbles in the abscess 22 (47.8%) 12 (48.0%) 0.848 0.900 0.31; 2.64
Number of air bubbles in the abscess 24 (52.2%)
(0 bubbles)
11 (23.9%)
(1 bubble)
11 (23.9%)
(>1 bubble)
8 (32.0%)
(0 bubbles)
4 (16.0%)
(1 bubble)
8 (32.0%)
(>1 bubble)
0.839 1.320 0.44; 3.96
Presence of retroperitoneal air bubbles - 2 (8.0%) 0.025 13.300 1.61; 291.0
Presence of extraluminal air at distance 3 (6.5%) 5 (20.0%) 0.043 4.480 1.96; 20.91
Presence of free pelvic fluid 6 (13.0%) 3 (12.0%) 0.890 1.110 0.25; 4.95
CT-guided percutaneous drainage of the abscess 7 (15.2%) 1 (4.0%) 0.153 0.232 0.03;2.01
Duration of symptoms before hospital admission (>3 Days) (N. %) 26 (56.5%) 18 (72.0%) 0.199 1.980 0.69; 5.65
Time spent in the emergency department (minutes) ± mean difference (MD) 303.0 ± 187.2 203.0 ± 40.8 0.111 276.68 −0.27; 0.79
Day of the admission 0.608 1.39 0.39; 4.95
Weekdays 39 (84.8%) 20 (80.0%)
Weekends 7 (15.2%) 5 (20.0%)